Y Intercept Hong Kong Ltd Invests $4.65 Million in Option Care Health, Inc. $OPCH

Y Intercept Hong Kong Ltd purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 143,016 shares of the company’s stock, valued at approximately $4,645,000. Y Intercept Hong Kong Ltd owned approximately 0.09% of Option Care Health as of its most recent filing with the SEC.

Other institutional investors also recently modified their holdings of the company. Compass Wealth Management LLC raised its holdings in shares of Option Care Health by 8.9% during the 1st quarter. Compass Wealth Management LLC now owns 166,078 shares of the company’s stock worth $5,804,000 after buying an additional 13,600 shares in the last quarter. Bessemer Group Inc. raised its holdings in shares of Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after buying an additional 599 shares in the last quarter. Principal Financial Group Inc. raised its holdings in shares of Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company’s stock worth $16,981,000 after buying an additional 6,616 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock worth $289,000 after buying an additional 1,691 shares in the last quarter. Finally, GAMMA Investing LLC raised its holdings in shares of Option Care Health by 307.1% during the 1st quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock worth $112,000 after buying an additional 2,408 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Activity at Option Care Health

In other Option Care Health news, Director Timothy P. Sullivan bought 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The shares were bought at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the transaction, the director directly owned 49,229 shares in the company, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Norman L. Wright bought 3,411 shares of the business’s stock in a transaction that occurred on Tuesday, September 9th. The shares were acquired at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the transaction, the director owned 15,501 shares in the company, valued at $454,334.31. This represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 59,411 shares of company stock worth $1,627,576 in the last 90 days. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Trading Up 1.3%

NASDAQ OPCH opened at $28.20 on Wednesday. The business’s 50-day moving average price is $27.98 and its two-hundred day moving average price is $29.99. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The firm has a market capitalization of $4.58 billion, a PE ratio of 22.56, a price-to-earnings-growth ratio of 1.69 and a beta of 0.88. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.35 billion. During the same quarter in the previous year, the company posted $0.30 EPS. The business’s revenue was up 15.4% on a year-over-year basis. On average, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on OPCH. JMP Securities boosted their price target on Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a report on Thursday, July 31st. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a report on Tuesday, September 23rd. Morgan Stanley initiated coverage on Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price for the company. Citigroup reaffirmed an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. Finally, Cowen initiated coverage on Option Care Health in a report on Thursday, October 2nd. They issued a “hold” rating for the company. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.10.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.